In a bid to expand its presence into the life sciences research market, GE Healthcare reported that it will initiate a tender offer for protein interaction analysis systems developer Biacore International.
The Uppsala, Sweden-based Biacore's products are used in areas such as antibody characterization, proteomics, lead characterization, immunogenicity, biotherapeutic development, and production.
GE said it will offer 330 Swedish kronor ($45 U.S.) per share in cash, for a total of approximately 2.9 billion kronor ($390 million), for Biacore. The offer is expected to commence on July 10 this year, according to GE of Chalfont St. Giles, U.K.
By AuntMinnie.com staff writers
June 20, 2006
Related Reading
GE adds to remote IT services, June 19, 2006
GE gets vet CT install, June 14, 2006
GE enables VIP ultrasound at Emory Clinic, June 13, 2006
GE announces new CT advances, June 13, 2006
GE investigates Omniscan cases, June 12, 2006
Copyright © 2006 AuntMinnie.com
